查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030027

數位表現型分析市場－全球產業規模、佔有率、趨勢、機會和預測：按資料流、設備類型、應用、地區和競爭格局分類，2021-2031年

Digital Phenotyping Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Data Stream, By Device Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球數位表現型市場預計將從 2025 年的 18.3 億美元成長到 2031 年的 31.4 億美元，複合年成長率為 9.42%。

該領域專注於透過結合使用者直接互動和被動感測器測量，利用從個人數位工具收集的數據，持續即時測量可觀察的個體特徵和行為。市場成長的主要驅動力是全球心理健康問題和慢性疾病的日益普遍，以及智慧型手機和穿戴式裝置的普及，這些裝置能夠實現無縫數據收集。此外，預防性醫療保健的興起，以及人工智慧 (AI) 和機器學習在複雜數據分析方面的快速發展，也進一步推動了這一領域的擴張。

市場概覽
預測期 2027-2031
市場規模：2025年 18.3億美元
市場規模：2031年 31.4億美元
複合年成長率：2026-2031年 9.42%
成長最快的細分市場 智慧型手機
最大的市場 北美洲

然而，資料隱私和複雜的監管要求等重大障礙阻礙了數位表現型技術的廣泛市場應用。由於持續記錄的個人健康資訊高度敏感，因此資料收集、儲存和使用必須遵循嚴格的倫理指南和標準化流程。儘管目前仍在製定全面的行業統計數據，但美國醫學會 (AMA) 2024 年的一份報告強調了該市場對人工智慧技術的日益依賴，目前已有約 66% 的醫生在使用人工智慧 (AI)。

市場促進因素

全球數位表現型分析市場的主要驅動力是智慧型手機和穿戴式電子設備的廣泛普及，這為無縫、持續的數據收集提供了必要的基礎。這些日常使用的數位設備能夠無縫記錄使用者主動輸入和被動感測器測量數據，從而為長期評估個體的生理特徵和習慣奠定基礎。這項技術的普及確保了用於表現型分析的豐富多樣的資料流。電訊（ITU）2025年10月發布的報告也印證了這一趨勢：到2025年，全球10歲及以上人群中將有82%擁有行動電話。如此廣泛的設備擁有量擴大了數據生成平台的覆蓋範圍，並顯著提升了數位表現型分析在不同人群和醫療保健領域未來的影響和應用範圍。

此外，人工智慧 (AI) 和機器學習 (ML) 的突破也推動了市場成長。這些技術突破對於解讀個人設備產生的大量、複雜且通常非結構化的信息至關重要。先進的 AI 和 ML 模型能夠識別複雜模式、進行預測評估，並從整合的數位表現型中提取有價值的臨床見解，將原始測量數據轉化為可用於個人化和預防性醫療保健的實用工具。根據矽谷銀行於 2026 年 1 月發布的第 17 份醫療保健投資與退出報告，2025 年總投資額的 46% 投向了醫療保健 AI 公司，這凸顯了對尖端分析技術的高度依賴，以最大限度地發揮數位健康資訊的效用。 Rock Health 於 2026 年 4 月發布的《第一季數位健康資金籌措摘要報告》更全面地反映了這一發展勢頭。該報告指出，到 2026 年第一季，數位健康新創公司將籌集 40 億美元的創業投資投資，這表明投資者對該行業持續擴張充滿信心。

市場挑戰

資料隱私問題和複雜的法規環境是數位表現型技術廣泛應用的主要障礙。透過這些方法不斷收集高度敏感的個人健康訊息，因此需要強力的倫理指南和統一的標準來規範資料的收集、儲存和使用。嚴格的數據監控和合規要求往往會導致該領域公司開發週期延長和營運成本增加。此外，不同地區法律體系的不確定性也增加了市場准入和擴張的難度，最終阻礙了資金籌措並減緩了技術進步。

這些障礙直接阻礙了先進數位表現型系統的應用。醫療資訊管理主管協會 (CHIME) 基金會 2025 年 12 月的一項調查發現，僅有 59% 的醫療機構在實施人工智慧 (AI) 之前就制定了正式的、有據可查的核准流程。這凸顯了數位表現型等工具在營運監管方面存在嚴重不足，而這些工具高度依賴 AI 進行複雜的數據解讀。缺乏標準化、透明的核准流程阻礙了醫療機構接受和充分利用這些技術，從而限制了市場擴張，並阻礙了數位表現型平台的更廣泛應用。

市場趨勢

一個顯著的市場趨勢是，數位表現型分析在藥物研發和臨床試驗的應用日益廣泛。透過利用智慧型裝置提供的持續性真實世界數據，研究人員可以簡化藥物研發流程，擺脫傳統的、間歇性的資料收集方法。這種應用提高了患者追蹤的準確性，確保了治療依從性，並能更早地識別治療結果，從而提升了臨床研究的準確性和效率。一篇發表於2026年3月《自然綜述：藥物發現》（Nature Reviews Drug Discovery）的論文強調了對這些技術在可靠數據收集方面日益成長的依賴性，該論文指出，到2025年，已有1021項干預試驗將穿戴式設備的數據納入了其調查方法。這種轉變將促進更靈活、以患者為中心的研究框架的構建，最終形成更全面的數據池，並為新的醫療療法提供更有力的證據。

另一個大趨勢是數位表現型分析和數位生物標記的融合，以推進精準診斷。此策略依賴於利用被動收集的數位指標來識別可測量的行為和生理徵兆，從而實現更準確、更個人化的疾病預測、追蹤或診斷。在表現型分析技術的支持下，數位生物標記能夠進行持續且無偏的評估，這對於制定個人化治療方案至關重要。例如，2026年1月的一份報告指出，WHOOP於2025年4月獲得了FDA 510(k)認證，其心電圖(ECG)功能得以實現，這有效地將一款市售穿戴裝置提升為醫療診斷工具。此類監管核准對於將數位表現型分析的洞見整合到現有的患者特定診斷流程中至關重要。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位表現型分析市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 資料流細分（主動資料{社群媒體活動、影片/音訊錄製、調查回應}，被動資料{GPS座標、Wi-Fi、藍牙連線、加速感應器資料、其他}）
    • 設備類型（智慧型手機、穿戴式醫療設備、地面振動感測器、其他）
    • 依應用領域（情緒障礙、躁鬱症、鴉片類藥物過量檢測、有害飲酒行為等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美數位表現型分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲數位表現型分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區數位表現型分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲數位表現型市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲數位表現型分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球數位表現型市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Black Dog Institute
  • Mindstrong Inc.
  • Sharecare, Inc.
  • Alphabet, Inc.
  • Cogito Corp.
  • Biogen Inc.
  • Roche Holding AG
  • Alphabet Inc.
  • Apple Inc.
  • Samsung Electronics Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 8106

The Global Digital Phenotyping Market is anticipated to expand from USD 1.83 billion in 2025 to USD 3.14 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.42%. This field centers on the continuous, real-time measurement of a person's observable characteristics and behaviors using data gathered from personal digital tools, combining direct user interactions with passive sensor readings. Market growth is primarily driven by the increasing worldwide prevalence of mental health and chronic disorders, alongside the massive uptake of smartphones and wearables that allow for seamless data collection. The shift toward preventive healthcare, coupled with rapid breakthroughs in artificial intelligence and machine learning for complex data analysis, further propels this expansion.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.83 Billion
Market Size 2031USD 3.14 Billion
CAGR 2026-20319.42%
Fastest Growing SegmentSmartphones
Largest MarketNorth America

However, widespread market acceptance is hindered by major hurdles related to data privacy and intricate regulatory requirements. The highly sensitive nature of continuously recorded personal health information demands strict ethical guidelines and uniform procedures for data gathering, retention, and application. While comprehensive industry-specific statistics for digital phenotyping are still developing, a 2024 report by the American Medical Association noted that roughly 66% of physicians were already utilizing artificial intelligence, highlighting the growing reliance on the AI technologies that form the backbone of this market.

Market Driver

A primary driver for the Global Digital Phenotyping Market is the extensive use of smartphones and wearable electronics, which supply the necessary foundation for seamless and continuous data gathering. These everyday digital devices seamlessly record both deliberate user inputs and passive sensor metrics, forming the basis for evaluating a person's visible traits and habits over an extended period. The widespread presence of this technology guarantees an abundant and diverse flow of data for phenotyping purposes. Highlighting this trend, an October 2025 update from the International Telecommunication Union reported that 82 percent of people aged 10 and older worldwide owned a mobile phone in 2025. Such extensive device ownership broadens the accessibility of data-producing platforms, significantly boosting the prospective influence and coverage of digital phenotyping across varied demographics and medical settings.

The market is additionally propelled by major leaps forward in artificial intelligence and machine learning. These technological breakthroughs are vital for interpreting the massive, intricate, and typically unstructured volumes of information generated by personal devices. Advanced AI and ML models facilitate complex pattern identification, predictive assessments, and the extraction of valuable clinical knowledge from combined digital phenotypes, turning raw metrics into practical tools for individualized and preventive healthcare. According to Silicon Valley Bank's January 2026 '17th Healthcare Investments and Exits Report', investments in healthcare AI firms accounted for 46% of total expenditures in 2025, emphasizing a strong dependence on cutting-edge analytics to maximize the utility of digital health information. Furthermore, a broader indicator of this momentum was noted in Rock Health's April 2026 'Q1 digital health funding recap report', which revealed that digital health startups secured $4 billion in venture capital during the first quarter of 2026, demonstrating unwavering investor faith in the industry's ongoing expansion.

Market Challenge

Data privacy concerns and complex regulatory environments present substantial barriers to the widespread acceptance of digital phenotyping. Because the constant stream of personal health information gathered through these methods is highly sensitive, it requires strong ethical guidelines and uniform standards governing how data is obtained, kept, and utilized. The necessity for rigorous data oversight and regulatory adherence frequently results in longer development cycles and increased operational costs for companies in this space. Additionally, the unpredictable nature of shifting legal frameworks in different regions makes entering and expanding within the market more difficult, which ultimately discourages financial backing and decelerates technological progress.

These obstacles directly impede the rollout of sophisticated digital phenotyping systems. A December 2025 survey conducted by the College of Healthcare Information Management Executives (CHIME) Foundation revealed that merely 59% of healthcare institutions possessed a formal, documented approval procedure prior to deploying artificial intelligence. This finding highlights a significant shortfall in the operational oversight necessary for tools like digital phenotyping, which heavily depend on AI for intricate data interpretation. The lack of standardized and transparent authorization protocols fosters reluctance among medical providers to embrace and maximize these technologies, consequently restricting market expansion and preventing the broader use of digital phenotyping platforms.

Market Trends

A prominent trend in the market is the increasing use of digital phenotyping within pharmaceutical research and clinical trials. By utilizing ongoing, real-world information from smart devices, researchers can streamline drug development and move past traditional, intermittent data gathering methods. This incorporation boosts the accuracy and productivity of clinical studies by offering better patient tracking, ensuring treatment compliance, and identifying therapeutic outcomes sooner. Highlighting the rising dependence on these techniques for reliable data collection, a March 2026 publication in Nature Reviews Drug Discovery noted that 1,021 interventional trials registered through 2025 included data sourced from wearables in their methodologies. This transition fosters more flexible, patient-focused study frameworks, ultimately yielding more comprehensive data pools and stronger evidence for new medical treatments.

Another major trend is the fusion of digital phenotyping with digital biomarkers to propel precision diagnostics forward. This strategy relies on passively gathered digital metrics to pinpoint measurable behavioral and physiological signs, which helps forecast, track, or diagnose medical conditions with greater exactness and individualization. Supported by phenotyping technologies, digital biomarkers allow for the constant and unbiased evaluations needed to create customized treatment plans. Demonstrating this successful blending of technologies, a January 2026 report stated that WHOOP received FDA 510(k) clearance for its ECG functionality in April 2025, effectively elevating a commercial wearable into a medical diagnostic tool. This kind of regulatory approval is essential for embedding insights gained from digital phenotyping into established, patient-specific diagnostic routines.

Key Market Players

  • Black Dog Institute
  • Mindstrong Inc.
  • Sharecare, Inc.
  • Alphabet, Inc.
  • Cogito Corp.
  • Biogen Inc.
  • Roche Holding AG
  • Alphabet Inc.
  • Apple Inc.
  • Samsung Electronics Co., Ltd.

Report Scope

In this report, the Global Digital Phenotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Phenotyping Market, By Data Stream

  • Active
  • Passive

Digital Phenotyping Market, By Device Type

  • Smartphones
  • Wearable Medical Devices
  • Geophones
  • Others

Digital Phenotyping Market, By Application

  • Mood Disorders
  • Bipolar Disorder
  • Opioid Overdose Detection
  • Harmful Alcohol Drinking Behaviour
  • Others

Digital Phenotyping Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Phenotyping Market.

Available Customizations:

Global Digital Phenotyping Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Phenotyping Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Data Stream (Active {Social Media Activity, Video/Audio Recordings, Survey Responses}, Passive {GPS Coordinates, Wi-Fi, Bluetooth Connectivity, Accelerometer Data, Others})
    • 5.2.2. By Device Type (Smartphones, Wearable Medical Devices, Geophones, Others)
    • 5.2.3. By Application (Mood Disorders, Bipolar Disorder, Opioid Overdose Detection, Harmful Alcohol Drinking Behaviour, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Digital Phenotyping Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Data Stream
    • 6.2.2. By Device Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Phenotyping Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Data Stream
        • 6.3.1.2.2. By Device Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Digital Phenotyping Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Data Stream
        • 6.3.2.2.2. By Device Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Digital Phenotyping Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Data Stream
        • 6.3.3.2.2. By Device Type
        • 6.3.3.2.3. By Application

7. Europe Digital Phenotyping Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Data Stream
    • 7.2.2. By Device Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Phenotyping Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Data Stream
        • 7.3.1.2.2. By Device Type
        • 7.3.1.2.3. By Application
    • 7.3.2. France Digital Phenotyping Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Data Stream
        • 7.3.2.2.2. By Device Type
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Digital Phenotyping Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Data Stream
        • 7.3.3.2.2. By Device Type
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Digital Phenotyping Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Data Stream
        • 7.3.4.2.2. By Device Type
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Digital Phenotyping Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Data Stream
        • 7.3.5.2.2. By Device Type
        • 7.3.5.2.3. By Application

8. Asia Pacific Digital Phenotyping Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Data Stream
    • 8.2.2. By Device Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Phenotyping Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Data Stream
        • 8.3.1.2.2. By Device Type
        • 8.3.1.2.3. By Application
    • 8.3.2. India Digital Phenotyping Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Data Stream
        • 8.3.2.2.2. By Device Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Digital Phenotyping Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Data Stream
        • 8.3.3.2.2. By Device Type
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Digital Phenotyping Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Data Stream
        • 8.3.4.2.2. By Device Type
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Digital Phenotyping Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Data Stream
        • 8.3.5.2.2. By Device Type
        • 8.3.5.2.3. By Application

9. Middle East & Africa Digital Phenotyping Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Data Stream
    • 9.2.2. By Device Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Phenotyping Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Data Stream
        • 9.3.1.2.2. By Device Type
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Digital Phenotyping Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Data Stream
        • 9.3.2.2.2. By Device Type
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Digital Phenotyping Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Data Stream
        • 9.3.3.2.2. By Device Type
        • 9.3.3.2.3. By Application

10. South America Digital Phenotyping Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Data Stream
    • 10.2.2. By Device Type
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Phenotyping Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Data Stream
        • 10.3.1.2.2. By Device Type
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Digital Phenotyping Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Data Stream
        • 10.3.2.2.2. By Device Type
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Digital Phenotyping Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Data Stream
        • 10.3.3.2.2. By Device Type
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Phenotyping Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Black Dog Institute
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Mindstrong Inc.
  • 15.3. Sharecare, Inc.
  • 15.4. Alphabet, Inc.
  • 15.5. Cogito Corp.
  • 15.6. Biogen Inc.
  • 15.7. Roche Holding AG
  • 15.8. Alphabet Inc.
  • 15.9. Apple Inc.
  • 15.10. Samsung Electronics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer